Abstract

The spectroscopic variant of magnetic resonance, magnetic resonance spectroscopy (MRS) allows the non-invasive detection and identification of a wide repertoire of molecules in solution which are present in cells and tissues in the millimolar range. Lactate, alanine, NMR-visible mobile lipids/Macromolecules, N-acetyl aspartate, glutamine, glutamate, creatine, choline, taurine, glucose, glycine and myo-inositol are the most common substances that can be detected in normal brain and in brain tumors. It is suggested that the voxel or volume of Interest (VOI) is placed after having performed the MRI exam, preferably with contrast administration and that the acquisition parameters used are widely accepted and used in the MR community. When reporting on a Single Voxel (SV) MRS study in the context of the clinical diagnosis or staging of brain tumors, it is advisable to carry out an structured description of the spectrum that, assigns the peaks to known metabolites and, describes the relationships between one another.The quantitative analysis can range from simple methods such as ratios between metabolites to semi-automated systems such using a decision-support system (DSS). Three situations can be indicated for SV MRS in suspected brain tumors: discrimination between tumor and pseudotumoral lesion, tumor grading, and follow-up of brain tumors after treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.